PlainRecalls
FDA Devices Moderate Class II Ongoing

DxI 9000 Access Immunoassay Analyzer, C11137; in-vitro diagnostic

Reported: July 10, 2024 Initiated: April 18, 2024 #Z-2264-2024

Product Description

DxI 9000 Access Immunoassay Analyzer, C11137; in-vitro diagnostic

Reason for Recall

Beckman Coulter is recalling their DxI 9000 Access Immunoassay Analyzers, an in vitro diagnostic device used for the quantitative, semi-quantitative, or qualitative determination of various analyte concentrations found in human body fluids, by correction. The reason for the recall is: Beckman Coulter has determined that the DxI 9000 Access Immunoassay analyzer accepts calibrator values scanned from multiple calibrator cards when an operator configures a new calibrator lot. The analyzer accepts the calibrator lot values from any scanned calibrator card, regardless of the assay test code or calibrator material lot number. The software is not validating the integrity of each calibrator barcode scanned to ensure they are all from the same calibrator card. This includes all software versions and all DxI 9000 instruments that are currently in the field. This issue does not impact calibrator material with 2D calibrator card barcodes. This may cause a failed calibration curve. The health risk to patients is dependent upon the analytes that could be impacted by the error, to include receiving delayed or erroneous results. The issue was identified by Beckman Coulter while conducting a field action on DxI 9000 Access Immunoassay Analyzers.

Details

Recalling Firm
Beckman Coulter, Inc.
Units Affected
116 units
Distribution
Worldwide distribution.
Location
Chaska, MN

Frequently Asked Questions

What product was recalled?
DxI 9000 Access Immunoassay Analyzer, C11137; in-vitro diagnostic. Recalled by Beckman Coulter, Inc.. Units affected: 116 units.
Why was this product recalled?
Beckman Coulter is recalling their DxI 9000 Access Immunoassay Analyzers, an in vitro diagnostic device used for the quantitative, semi-quantitative, or qualitative determination of various analyte concentrations found in human body fluids, by correction. The reason for the recall is: Beckman Coulter has determined that the DxI 9000 Access Immunoassay analyzer accepts calibrator values scanned from multiple calibrator cards when an operator configures a new calibrator lot. The analyzer accepts the calibrator lot values from any scanned calibrator card, regardless of the assay test code or calibrator material lot number. The software is not validating the integrity of each calibrator barcode scanned to ensure they are all from the same calibrator card. This includes all software versions and all DxI 9000 instruments that are currently in the field. This issue does not impact calibrator material with 2D calibrator card barcodes. This may cause a failed calibration curve. The health risk to patients is dependent upon the analytes that could be impacted by the error, to include receiving delayed or erroneous results. The issue was identified by Beckman Coulter while conducting a field action on DxI 9000 Access Immunoassay Analyzers.
Which agency issued this recall?
This recall was issued by the FDA Devices on July 10, 2024. Severity: Moderate. Recall number: Z-2264-2024.